Aridis Pharmaceuticals Inc
General ticker "ARDS" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $3.6K
Aridis Pharmaceuticals Inc does not follow the US Stock Market performance with the rate: -35.0%.
Estimated limits based on current volatility of 47.2%: low 0.00$, high 0.00$
Factors to consider:
- Current price 100.0% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [0.56$, 1.66$]
- 2023-12-31 to 2024-12-30 estimated range: [0.58$, 1.67$]
Short-term ARDS quotes
Long-term ARDS plot with estimates
Financial data
| YTD | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|
| Operating Revenue | $1.00MM | $1.53MM | $3.09MM |
| Operating Expenses | $23.40MM | $44.25MM | $33.08MM |
| Operating Income | $-22.40MM | $-42.71MM | $-29.99MM |
| Non-Operating Income | $0.07MM | $0.58MM | $0.32MM |
| Interest Expense | $0.00MM | $0.24MM | $0.38MM |
| R&D Expense | $16.96MM | $37.94MM | $25.92MM |
| Income(Loss) | $-22.33MM | $-42.13MM | $-29.67MM |
| Profit(Loss) | $-22.33MM | $-42.13MM | $-29.67MM |
| Stockholders Equity | $-8.68MM | $-13.11MM | $-24.23MM |
| Inventory | $0.37MM | $0.24MM | $0.00MM |
| Assets | $15.12MM | $26.80MM | $14.70MM |
| Operating Cash Flow | $-20.48MM | $-22.94MM | $-29.13MM |
| Capital expenditure | $0.37MM | $0.53MM | $0.08MM |
| Investing Cash Flow | $-0.37MM | $-0.53MM | $-0.08MM |
| Financing Cash Flow | $8.68MM | $34.72MM | $14.78MM |
| Earnings Per Share* | $-2.39 | $-3.44 | $-1.64 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.